A client arrives at the healthcare setting currently taking atorvastatin (Lipitor) daily. Which assessment finding associated with atorvastatin (Lipitor) would need immediate reporting to the healthcare provider?
bradycardia
dark-red urine
elevated HDL cholesterol
migraine headache
The Correct Answer is B
A. Bradycardia is not a common side effect of atorvastatin and would not necessarily require immediate reporting unless it is significantly low and symptomatic.
B. Dark-red urine could indicate the presence of myoglobinuria, which can occur due to rhabdomyolysis, a serious side effect of statins like atorvastatin that necessitates immediate medical attention.
C. Elevated HDL cholesterol is generally a positive finding and does not require reporting unless it is part of a larger adverse effect context.
D. A migraine headache, while concerning, is not a known side effect specifically associated with atorvastatin and may not require immediate intervention unless severe or persistent.
Free Nursing Test Bank
- Free Pharmacology Quiz 1
- Free Medical-Surgical Quiz 2
- Free Fundamentals Quiz 3
- Free Maternal-Newborn Quiz 4
- Free Anatomy and Physiology Quiz 5
- Free Obstetrics and Pediatrics Quiz 6
- Free Fluid and Electrolytes Quiz 7
- Free Community Health Quiz 8
- Free Promoting Health across the Lifespan Quiz 9
- Free Multidimensional Care Quiz 10
View Related questions
Correct Answer is B
Explanation
A. Daily weight monitoring is not specifically indicated for doxazosin, and significant weight loss is typically not a primary concern with this medication.
B. Doxazosin can cause first-dose hypotension, leading to dizziness; thus, the client should be advised to lie down after the initial dose to minimize this risk.
C. Increasing potassium intake is not necessary with doxazosin; there are no direct interactions that would warrant dietary changes regarding potassium.
D. Impaired taste is not a commonly reported side effect of doxazosin; this statement is misleading and not relevant to the medication's profile.
Correct Answer is ["A","B","E"]
Explanation
A. Decongestants are commonly used to relieve nasal congestion in upper respiratory tract infections by constricting blood vessels in the nasal passages.
B. Expectorants help thin mucus and are used in upper respiratory conditions to facilitate coughing up mucus.
C. H2 antagonists are primarily used to reduce stomach acid and are not indicated for upper respiratory conditions.
D. Short-acting beta agonists (SABAs) are primarily used in the management of lower respiratory tract conditions, such as asthma and COPD, rather than upper respiratory conditions.
E. H1 antagonists (antihistamines) are effective for treating allergic reactions and symptoms of upper respiratory infections, such as runny nose and sneezing.
F. Long-acting beta agonists (LABAs) are also used primarily for lower respiratory tract conditions and are not appropriate for treating upper respiratory issues.